Deep Dive: FDA to revoke Red No. 3 authorization
January 15th 2025, the FDA announced that they would be revoking their authorizations for Red No. 3 in food and ingested drugs. The Lycored team comments on the situation.
2014 Asian Seminars
Nov 14, 2014
This October, The Lycored Team flew into Japan and China to lead a free lecture series on natural science and targeted wellness, sharing insights on the evolution of the dietary supplements market with our brand advocates and the trade.
Continue reading
Lycomato Longevity and Cellular Aging Webinar 2024
In our latest webinar, Elizabeth Tarshish, PhD, Head of Scientific Value & Strategy at Lycored discusses Lycomato’s impact on cellular and mitochondrial health and how it promotes longevity through a...
A Personal Thank You from Shirley ❤️
Reflecting on my fourth year at Lycored, I'm filled with gratitude for our incredible journey together in 2024.
We're here for you
Interested in speaking directly with a member of our team?
Click below to get in touch.